Annovis Bio, Inc.
NYSE · CIK 0001477845 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Annovis Bio, Inc. | 2026-05-21 | 0001104659-26-065311 |
| 10-Q | Annovis Bio, Inc. | 2026-05-15 | 0001104659-26-062626 |
| 4 | Annovis Bio, Inc. | 2026-04-03 | 0001104659-26-039675 |
| 10-K | Annovis Bio, Inc. | 2026-03-13 | 0001104659-26-027751 |
| 4 | Annovis Bio, Inc. | 2025-12-08 | 0001104659-25-119407 |
| 4 | Annovis Bio, Inc. | 2025-11-25 | 0001104659-25-115801 |
| 4 | Annovis Bio, Inc. | 2025-11-21 | 0001104659-25-115090 |
| 4 | Annovis Bio, Inc. | 2025-11-18 | 0001104659-25-113459 |
| 10-Q | Annovis Bio, Inc. | 2025-11-12 | 0001104659-25-110393 |
| 4 | Annovis Bio, Inc. | 2025-11-12 | 0001104659-25-109906 |
| 4 | Annovis Bio, Inc. | 2025-11-12 | 0001104659-25-109905 |
| 4 | Annovis Bio, Inc. | 2025-11-12 | 0001104659-25-109904 |
| 4 | Annovis Bio, Inc. | 2025-09-03 | 0001104659-25-087077 |
| 4 | Annovis Bio, Inc. | 2025-08-20 | 0001104659-25-080981 |
| 10-Q | Annovis Bio, Inc. | 2025-08-12 | 0001558370-25-011233 |